Page 6,225«..1020..6,2246,2256,2266,227..6,2306,240..»

Touro Idol Interview – Kimdavy Chheng – Video

Posted: Published on November 10th, 2012

Touro Idol Interview - Kimdavy Chheng Our first college of pharmacy interview in the series. Enjoy!From:Pharmadillo2016Views:0 0ratingsTime:03:17More inPeople Blogs Read the original post: Touro Idol Interview - Kimdavy Chheng - Video … Continue reading

Posted in Pharmacy | Comments Off on Touro Idol Interview – Kimdavy Chheng – Video

CVS Pharmacy Finds for Friday November 9th 2012 ! – Video

Posted: Published on November 10th, 2012

CVS Pharmacy Finds for Friday November 9th 2012 ! From:countryboynick83Views:0 0ratingsTime:03:27More inPeople Blogs See the rest here: CVS Pharmacy Finds for Friday November 9th 2012 ! - Video … Continue reading

Posted in Pharmacy | Comments Off on CVS Pharmacy Finds for Friday November 9th 2012 ! – Video

Layoffs at firm tied to Mass. pharmacy in outbreak

Posted: Published on November 10th, 2012

BOSTON (AP) A Massachusetts company with the same founders as a pharmacy tied to a deadly meningitis outbreak said Thursday it is laying off nearly all its employees amid a prolonged closure for inspection. Employees at Ameridose LLC, which produces drugs for hospital pharmacies, were notified of the layoffs in a letter Thursday. The notice affects 650 employees at Ameridose and 140 employees at its marketing and support arm, Medical Sales Management, said Ameridose spokesman Andrew Paven. The Westborough company has paid its employees since it voluntarily closed for inspection Oct. 10 because of problems at its sister company, the New England Compounding Center pharmacy in Framingham near Boston. The meningitis outbreak, which has spread to 19 states and sickened more than 400 people, 31 of whom have died, has been linked to a steroid made by the NECC. No problems have been linked to Ameridose products. But last week, the company recalled all its products after U.S. Food and Drug Administration officials told the company it must improve its sterility testing. A small number of Ameridose workers will be retained amid the recall and to implement changes that federal regulators are expected to recommend, Paven said. The mass layoffs … Continue reading

Posted in Pharmacy | Comments Off on Layoffs at firm tied to Mass. pharmacy in outbreak

CVS/pharmacy and CVS Caremark Charitable Trust Continue to Support Communities Affected by Hurricane Sandy

Posted: Published on November 10th, 2012

WOONSOCKET, R.I., Nov. 9, 2012 /PRNewswire/ --As communities in New Jersey and New York continue to recover from Hurricane Sandy, CVS/pharmacy has re-opened nearly all of its stores in affected areas and is assisting with local disaster relief efforts. (Logo: http://photos.prnewswire.com/prnh/20100816/NE50800LOGO ) Access to Stores More than 1,200 CVS/pharmacy locations have reopened since the storm struck the East Coast and CVS is using generators in about 60 stores located in areas that are still experiencing power outages. Only 16 stores remain closed due to water or wind damage. In two of the hardest-hit areas in which CVS/pharmacy stores will remain closed for an extended period of time, the Company will operate mobile pharmacies at the sites of the closed stores in order to ensure that these communities will continue to have access to their prescribed medications. CVS/pharmacy is now operating a mobile pharmacy at the site of its closed store at 9301 Ventnor Avenue in Margate City, NJ. Next week, CVS/pharmacy will begin operating a second mobile pharmacy at the site of its closed store at 88-07 Rockaway Beach Boulevard in Rockaway Beach, NY. "CVS/pharmacy is committed to ensuring that the communities we serve have access to pharmacy services and … Continue reading

Posted in Pharmacy | Comments Off on CVS/pharmacy and CVS Caremark Charitable Trust Continue to Support Communities Affected by Hurricane Sandy

Progress in FSHD Muscular Dystrophy Research Hailed at International Meeting

Posted: Published on November 9th, 2012

Recent scientific breakthroughs are offering real hope for patients living with one of the most common forms of muscular dystrophy. Scientists from around the world converged on San Francisco for the FSH Society's International Research Consortium meeting to share the latest advances in facioscapulohumeral muscular dystrophy (FSHD) research, including a new genetic explanation for the muscle-wasting disease. San Francisco, CA (PRWEB) November 08, 2012 Thanks to the efforts of Perez and many other patients, FSHD research has come a long way. The evidence was there for all to see at the FSH Societys 2012 International Research Consortium & Research Planning Meeting, held on November 6, 2012, in conjunction with the annual meeting of the American Society of Human Genetics in San Francisco, CA. The biggest buzz at the meeting was generated by the discovery of a new gene for FSHD by scientists from the U.S., Netherlands and France. The study by Richard Lemmers and colleagues will be published in Nature Genetics on November 11. Over 90 percent of FSHD patients have a shortening of the D4Z4 region on chromosome 4, which results in the expression of a gene called DUX4, with apparent toxic effects in muscle. The newly found gene … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Progress in FSHD Muscular Dystrophy Research Hailed at International Meeting

Cedars-Sinai research: Preclinical muscular dystrophy data shows promise

Posted: Published on November 9th, 2012

Public release date: 7-Nov-2012 [ | E-mail | Share ] Contact: Sally Stewart Sally.stewart@cshs.org 310-248-6566 Cedars-Sinai Medical Center LOS ANGELES Nov. 7, 2012 Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder. The researchers studied HCT 1026, a new type of molecule in which nitric oxide is chemically attached to a standard anti-inflammatory agent, in a preclinical model of muscular dystrophy. Results suggest HCT 1026 may be beneficial for the treatment of Duchenne muscular dystrophy, which begins in early childhood, and Becker muscular dystrophy, which often occurs later in adulthood. Preliminary results were presented in April 2012 at the experimental Biology meeting and now the full study is published in the Public Library of Science (PLOS ONE) and is available online. Both forms of muscular dystrophy are caused by problems with a protein called dystrophin, which helps maintain healthy muscles. If patients have less dystrophin protein or if their body manufactures dystrophin protein that does not function correctly, their muscles cannot work properly and eventually become permanently damaged. As diseased muscles weaken over time, patients gradually can lose … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Cedars-Sinai research: Preclinical muscular dystrophy data shows promise

Preclinical muscular dystrophy data shows promise

Posted: Published on November 9th, 2012

ScienceDaily (Nov. 7, 2012) Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder. The researchers studied HCT 1026, a new type of molecule in which nitric oxide is chemically attached to a standard anti-inflammatory agent, in a preclinical model of muscular dystrophy. Results suggest HCT 1026 may be beneficial for the treatment of Duchenne muscular dystrophy, which begins in early childhood, and Becker muscular dystrophy, which often occurs later in adulthood. Preliminary results were presented in April 2012 at the experimental Biology meeting and now the full study is published in PLoSONE and is available online. Both forms of muscular dystrophy are caused by problems with a protein called dystrophin, which helps maintain healthy muscles. If patients have less dystrophin protein or if their body manufactures dystrophin protein that does not function correctly, their muscles cannot work properly and eventually become permanently damaged. As diseased muscles weaken over time, patients gradually can lose their ability to walk, sit or use their muscles in other ways. There is no cure now for either form of the disease. "There is … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Preclinical muscular dystrophy data shows promise

Earlier Treatment Greatly Benefits Children With Autism

Posted: Published on November 9th, 2012

November 7, 2012 Connie K. Ho for redOrbit.com Your Universe Online Researchers from Yale School of Medicine recently discovered that, when provided earlier treatment, children with autism spectrum disorders (ASD) showed serious improvements in behavior, communication and brain function. Dr. Fred Volkmar, Kevin A. Pelphrey, and other researchers at the Yale Child Study Center published the study on early treatment, paving a way for brain change in autistic children. The findings were discussed in a recent issue of the Journal of Autism and Developmental Disorders. The brain systems related to social perception had positive reaction to the pivotal response treatment, a kind of early intervention behavioral program that was developed at the University of California, Santa Barbara. Along with parent training, the treatment included a section just focused on play and includes areas for learning and development. ASD is a heterogeneous disorder, and research aimed at understanding treatment must address this heterogeneity, noted Pelphrey in the statement. Both the children in our current study made progress, but their degree of progress and level of skills at the end of treatment were distinct. Researchers explained how pivotal response treatment could help children as young as two years of age. In the … Continue reading

Comments Off on Earlier Treatment Greatly Benefits Children With Autism

New Study: Early Treatment Helps Autism

Posted: Published on November 9th, 2012

By Rick Nauert PhD Senior News Editor Reviewed by John M. Grohol, Psy.D. on November 7, 2012 Emerging research suggests early treatment for children with autism spectrum disorders (ASD) can significantly improve behavior, stimulate communication and enhance brain function. Yale School of Medicine researchers have published their study findings in the Journal of Autism and Developmental Disorders. Researchers Fred Volkmar, M.D., Kevin A. Pelphrey, Ph.D.,and colleagues say the study findings suggest that brain systems supporting social perception can be improved when an early intervention behavioral program is administered. In the study, investigators used a technique called pivotal response treatment. This treatment includes parent training, and employs play in its methods. ASDs are complex neurobiological disorders that inhibit a persons ability to communicate and develop social relationships, and are often accompanied by behavioral challenges. Until recently, the diagnosis of autism diagnosis typically was not confirmed until a child was about three to five years-old. As a result, treatment programs were developed for this older age group. Today, Volkmar and his team are diagnosing children as young as age one. The combination of an early diagnosis and then application of the pivotal response treatment intervention has been revealing. Pivotal response treatment, developed … Continue reading

Comments Off on New Study: Early Treatment Helps Autism

Find puts treatment for autism closer

Posted: Published on November 9th, 2012

Scientists at Auckland University's Centre for Brain Research say they have gained new understandings of the causes of autism, opening up new avenues for possible treatment. The ground-breaking research, done in collaboration with Stanford University in the United States, looked at brain cell communication and genetic mutations in people with autism. The team discovered that autism was caused by mutated brain proteins, called Shank3, weakening communication between brain cells. Head researcher Jo Montgomery said that the discovery was exciting because it meant treatments could be investigated. "Brain cells are incredibly sociable cells in the brain and they talk to each other all the time," she said. "There are about 10 trillion brain cells connected by about 10 billion synapses which gives you an idea of how much chatter is going on in your brain at one time, and all that chatter underlies how you see things, how you move, how you learn and how you remember things. "What we showed is that when you have these autism-associated mutations, this changes how synapses in the brain function." Dr Montgomery said there was definitely reason to get excited about the possibilities for a cure for autism, at some stage in the future. … Continue reading

Comments Off on Find puts treatment for autism closer

Page 6,225«..1020..6,2246,2256,2266,227..6,2306,240..»